• Monday, May 18, 2020 @ 12:00 am

Scailyte and CHU Rennes have made an initial discovery of a single-cell biomarker for identification of Covid-19 patients at risk to become critically ill. Scailyte strives to deliver diagnostics that will allow pro-active clinical decisions and improve the outcome for Covid-19 patients. Their data science team is working on using this biomarker as a prediction for patients with chances of developing ARDS as a result of Covid-19 infection.


You may also be interested in